Autism and Fragile X-Associated Disorders

Speakers


Len Abbeduto, PhD

‘LANGUAGE INTERVENTION: A FAMILY-FOCUSED MODEL’

MIND Institute and Department of Psychiatry and Behavioral Sciences, School Of Medicine, University Of California, Davis Medical Center, Sacramento, CA, USA

Elizabeth M. Berry-Kravis, MD, PhD

‘CLINICAL TRIALS OF TARGETED TREATMENTS IN FRAGILE X SYNDROME’

Departments of Pediatrics, Neurological Sciences and Biochemistry, Rush University Medical Center, Chicago, IL, USA

Dejan B. Budimirovic, MD

‘AUTISM IN FRAGILE X SYNDROME: AN FMR1-FMRP MOLECULAR-BEHAVIORAL STUDY’

Kennedy Krieger Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Behavioral Sciences-Child Psychiatry, Johns Hopkins University School Of Medicine, Baltimore, MD, USA

Robert L. Findling, MD, MBA

‘THE PSYCHOPHARMACOLOGICAL TREATMENT OF AUTISM AND INTELLECTUAL DISABILITIES’

Kennedy Krieger Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Behavioral Sciences-Child Psychiatry, Johns Hopkins University School Of Medicine, Baltimore, MD, USA

Paul J. Hagerman, MD, PhD

‘FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME [FXTAS]’

MIND Institute And Department Of Biological Chemistry And Molecular Medicine, University Of California, Davis, CA, USA

Randi J. Hagerman, MD

‘AN INTRODUCTION TO THE PHENOTYPE, MEDICAL AND DEVELOPMENTAL CHARACTERISTICS AND SUPPORTIVE THERAPY OF FRAGILE X SYNDROME’

MIND Institute and Department of Pediatrics, University of California, Davis Medical Center, Sacramento, CA, USA

David Hessl, PhD

‘FRAGILE X ASSESSMENT FOR THE CLINIC AND RESEARCH: OVERCOMING CHALLENGES AND BARRIERS’

MIND Institute and Department of Psychiatry And Behavioral Sciences, School of Medicine, University of California, Davis Medical Center, Sacramento, CA, USA

Robert Miller

‘PATIENT ADVOCACY: BRIDGING THE GAPS BETWEEN SERVICES PROVIDED AND SERVICES DESIRED’

National Fragile X Foundation, Mc Lean, VA, USA

Ivana Novakovic, MD, PhD

‘GENETIC BASIS OF FRAGILE X CHROMOSOME: FROM PHENOTYPE TO GENOTYPE AND BACKWARD’

Institute of Human Genetics, School of Medicine, University Of Belgrade, Serbia

Stephanie Sherman, PhD

‘WOMEN'S HEALTH AND THE PREMUTATION’

Emory University, School Of Medicine, Atlanta, GA, USA

Flora Tassone, PhD

‘DNA TESTING AND THE MOLECULAR UNDERPINNING OF FRAGILE ASSOCIATED DISORDERS’

MIND Institute, University of California, Davis Medical Center, Sacramento, CA, USA

Stela Filipovic-Sadic

‘FRAGILE X TESTING: A DECADE OF PROGRESS’

Asuragen, Inc., Austin, TX, USA